Sleep Number’s fourth quarter was marked by a notable beat on revenue expectations, despite ongoing top-line pressures. Management attributed sequential improvement to the successful rollout of its new Comfort mode mattress and a streamlined product lineup, which CEO Linda Findley described as “3.5x what we expected and nearly twice all the sales of all 3 C Series beds that this bed replaces.” Leadership also emphasized the impact of $185 million in annualized cost reductions, which contributed to stronger-than-expected adjusted EBITDA and improved operational efficiency.

Is now the time to buy SNBR? Find out in our full research report (it’s free for active Edge members).

While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.

Our Top 5 Analyst Questions From Sleep Number’s Q4 Earnings Call

• Daniel Silverstein (UBS): Asked about the margin impact of new beds and the rationale behind targeting new customer demographics. CEO Linda Findley explained the focus was on comfort, value, and expanding access, while CFO Amy O’Keefe highlighted a “10 percentage point gross margin improvement” for the Comfort mode bed compared to legacy models.
• Robert Griffin (Raymond James): Inquired about the timing of the full product lineup rollout across stores. Findley confirmed all new beds would be available by March 23, with most stores reset by mid-April to capture Memorial Day demand.
• Sarah (Piper Sandler): Sought clarity on the trajectory of marketing spend in 2026. Findley noted spending would be flat year-over-year but more evenly allocated, with higher investment in quarters two through four to support new product launches.
• Sarah (Piper Sandler): Followed up regarding the impact of legacy product clearance on margins. O’Keefe acknowledged expected margin pressure in Q1 due to discounting but stressed the move was necessary to maximize the impact of the new product ramp.
• No further analyst questions: The session concluded without additional analyst inquiries.

Catalysts in Upcoming Quarters

In upcoming quarters, the StockStory team will watch (1) the adoption rate and sales mix shift tied to the new mattress portfolio, (2) the effectiveness of rebalanced marketing spend and the partnership with Travis Kelce in driving brand engagement, and (3) progress on cost reduction and liquidity initiatives, especially as refinancing efforts and operational restructuring unfold. Execution on these fronts will be critical to Sleep Number’s turnaround.

Sleep Number currently trades at $3.04, down from $4.59 just before the earnings. Is there an opportunity in the stock?See for yourself in our full research report (it’s free).

The Best Stocks for High-Quality Investors

ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.

Our AI system flagged Palantir before it ran 1,662%. AppLovin before it ran 753%. Nvidia before it ran 1,178%. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.